n Cardiovascular Journal of South Africa - PROactive study shows reduced heart attacks and strokes in type 2 diabetics on pioglitazone HCI (Actos®) therapy : drug trends
|Article Title||PROactive study shows reduced heart attacks and strokes in type 2 diabetics on pioglitazone HCI (Actos®) therapy : drug trends|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||Sep 2005|
|Pages||286 - 287|
The ambitious PROactive study, initiated in 2001, is the first prospective, randomised, double-blind, placebo-controlled trial of an oral glucose-lowering medication's ability to significantly improve cardiovascular outcomes over 2.5 years of therapy in type 2 diabetics. The study added pioglitazone to the treatment of type 2 diabetics who were already receiving standard-care therapy including dietary modification, glucose lowering (using metformin, sulphonylureas and insulin), blood pressure regulation, lipid lowering and antithrombotic agents, according to the 1999 IDF (European) guidelines.
Article metrics loading...